BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
33 results:

  • 1. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study.
    Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ
    Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nutritional status and its correlation to prognosis of nasopharyngeal carcinoma patients in different ages in China: a multicenter cohort study.
    Jia P; Wu X; Shen F; Xu G; Xu H; Cong M; Song C; Shi H
    Support Care Cancer; 2023 Oct; 31(12):638. PubMed ID: 37847417
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
    He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
    Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
    Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
    Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis.
    Xi Y; Zhang T; Sun W; Liang R; Ganesh S; Chen H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499755
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A neural-related gene risk score for head and neck squamous cell carcinoma.
    Tao ZY; Yang WF; Zhu WY; Wang LL; Li KY; Guan XY; Su YX
    Oral Dis; 2024 Mar; 30(2):477-491. PubMed ID: 36346196
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysis.
    Monteiro L; Mariano LC; Warnakulasuriya S
    Oral Dis; 2024 Mar; 30(2):207-215. PubMed ID: 36103586
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [prognosis of adenoid cystic carcinoma of head and neck and risk factors for lung metastasis].
    Wang XL; Zhou MJ; Ma TY; Jiang LY; Zhao QD; Xu HB; Zhou J; Li LF; Kong L; Chen X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Aug; 57(8):963-968. PubMed ID: 36058663
    [No Abstract]    [Full Text] [Related]  

  • 9. PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated head-and-neck cancer.
    Ito T; Okamoto I; Tokashiki K; Sato H; Okada T; Yamashita G; Nagao T; Hirai H; Saigusa N; Tsukahara K
    Anticancer Res; 2022 Mar; 42(3):1547-1554. PubMed ID: 35220251
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.
    Beaudoux O; Oudart JB; Riffaud L; Visseaux L; Marchal A; Lebre AS; Grange F
    Mol Diagn Ther; 2022 Mar; 26(2):189-202. PubMed ID: 35195858
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification novel prognostic signatures for head and neck Squamous Cell Carcinoma based on ceRNA network construction and immune infiltration analysis.
    Zhou H; He Y; Li L; Wu C; Hu G
    Int J Med Sci; 2021; 18(5):1297-1311. PubMed ID: 33526991
    [No Abstract]    [Full Text] [Related]  

  • 12. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in head and neck cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]    [Full Text] [Related]  

  • 13. An Immune-Related Gene Prognostic Index for head and neck Squamous Cell Carcinoma.
    Chen Y; Li ZY; Zhou GQ; Sun Y
    Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.
    Liu X; Huang Z; He X; Zheng X; Jia Q; Tan J; Fan Y; Lou C; Meng Z
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015713
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Improving identification of candidates for lung cancer screening in a high risk population.
    Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
    Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Validation Study of Fibrinogen and Albumin Score in Esophageal cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort Study.
    Matsuda S; Takeuchi H; Kawakubo H; Takemura R; Maeda Y; Hirata Y; Kaburagi T; Egawa T; Nishi T; Ogura M; Miyasho T; Okamura A; Mayanagi S; Fukuda K; Nakamura R; Irino T; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Feb; 28(2):774-784. PubMed ID: 32737701
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National cancer Database.
    Sathe TS; Resio BJ; Hoag JR; Monsalve AF; Pathak R; Blasberg JD; Mase V; Dhanasopon A; Boffa DJ
    Ann Thorac Surg; 2020 Jun; 109(6):1656-1662. PubMed ID: 32109449
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Utilities of
    Guan H; Toraldo G; Cerda S; Godley FA; Rao SR; McAneny D; Doherty G; Braverman L; Lee SL
    Thyroid; 2020 Apr; 30(4):536-547. PubMed ID: 31996097
    [No Abstract]    [Full Text] [Related]  

  • 20. The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.
    Zhi-Qiang W; Qi M; Ji-Bin L; Rui Y; You-Ping L; Rui S; Guang-Yuan H; Ming-Yuan C; Yi-Jun H
    BMC Cancer; 2019 Nov; 19(1):1122. PubMed ID: 31744469
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.